CFA
GILD icon

Camarda Financial Advisors’s Gilead Sciences GILD Stock Holding History

Camarda Financial Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-22,589
Closed -$2.77M – 109
2025
Q4 		$2.77M Buy
+22,589
New +$2.75M 1.06% 32
2025
Q2 		– Sell
-16,544
Closed -$1.85M – 107
2025
Q1 		$1.85M Buy
+16,544
New +$1.71M 0.84% 37
2022
Q4 		– Sell
-4,634
Closed -$286K – 84
2022
Q3 		$286K Buy
+4,634
New +$292K 0.34% 56
2020
Q3 		– Sell
-11,069
Closed -$852K – 49
2020
Q2 		$852K Sell
11,069
-1,351
-11% -$104K 1.19% 21
2020
Q1 		$929K Buy
12,420
+717
+6% +$49.5K 4.7% 9
2019
Q4 		$760K Buy
+11,703
New +$762K 1.61% 31
2019
Q3 		– Sell
-1,334
Closed -$90K – 215
2019
Q2 		$90K Hold
1,334
– – 0.18% 53
2019
Q1 		$87K Sell
1,334
-271
-17% -$18K 0.17% 61
2018
Q4 		$100K Sell
1,605
-12,224
-88% -$854K 0.12% 64
2018
Q3 		$1.07M Sell
13,829
-330
-2% -$24.9K 1.21% 18
2018
Q2 		$1M Sell
14,159
-362
-2% -$25.6K 1.05% 20
2018
Q1 		$1.09M Sell
14,521
-2,178
-13% -$173K 1.13% 24
2017
Q4 		$1.2M Sell
16,699
-2,080
-11% -$158K 1.43% 23
2017
Q3 		$1.52M Buy
18,779
+18,479
+6,160% +$1.41M 1.64% 24
2017
Q2 		$21K Hold
300
– – 0.02% 147
2017
Q1 		$20K Sell
300
-17
-5% -$1.2K 0.02% 138
2016
Q4 		$23K Buy
317
+17
+6% +$1.26K 0.02% 153
2016
Q3 		$24K Sell
300
-13,891
-98% -$1.13M 0.01% 137
2016
Q2 		$1.18M Buy
14,191
+2,912
+26% +$258K 0.75% 55
2016
Q1 		$1.04M Sell
11,279
-974
-8% -$87.8K 0.65% 56
2015
Q4 		$1.24M Buy
12,253
+1,642
+15% +$171K 0.76% 48
2015
Q3 		$1.04M Buy
+10,611
New +$1.18M 0.65% 55
2014
Q4 		– Sell
-595
Closed -$63K – 275
2014
Q3 		$63K Sell
595
-315
-35% -$30.8K 0.04% 109
2014
Q2 		$75K Buy
+910
New +$70.8K 0.05% 117

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Camarda Financial Advisors's GILD Position: Q1 2026 in Review

Camarda Financial Advisors sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 22,589 shares — an estimated $2.77M sold.

Camarda Financial Advisors first reported a position in GILD in Q2 2014 and held it in 24 quarters. The position peaked at $2.77M in Q4 2025. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Camarda Financial Advisors reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
  • Camarda Financial Advisors sold 22,589 Gilead Sciences shares in Q1 2026, an estimated $2.77M.
  • Camarda Financial Advisors first reported a position in Gilead Sciences in Q2 2014 and held it in 24 quarters.
  • Camarda Financial Advisors's Gilead Sciences position peaked at $2.77M in Q4 2025.
  • 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Camarda Financial Advisors's 13F filing for Q1 2026, filed 14 May 2026.